https://www.biotechblueprint.com/p/makary-resigns-bms-bets-15b-on-chinaBiotech Blueprinten2026-05-15T12:12:09+00:00Makary Resigns, BMS Bets $15B on China R&D, and Regenxbio Wins Phase 3 in Duchenne – This Week in Biotech #100